GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
+46.03%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$352M
AUM Growth
+$352M
Cap. Flow
+$96.4M
Cap. Flow %
27.4%
Top 10 Hldgs %
53.9%
Holding
48
New
11
Increased
10
Reduced
8
Closed
9
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
KDMN
26
DELISTED
Kadmon Holdings, Inc.
KDMN
$5.54M 1.45%
2,100,000
+100,000
+5% +$264K
VRAY
27
DELISTED
ViewRay, Inc.
VRAY
$5.54M 1.45%
750,000
ORTX
28
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$5.36M 1.4%
300,000
AXSM icon
29
Axsome Therapeutics
AXSM
$6.09B
$4.41M 1.15%
+310,000
New +$4.41M
BCRX icon
30
BioCryst Pharmaceuticals
BCRX
$1.74B
$4.07M 1.06%
500,000
CHMA
31
DELISTED
Chiasma, Inc. Common Stock
CHMA
$3.64M 0.95%
+700,000
New +$3.64M
ARVN icon
32
Arvinas
ARVN
$580M
$2.58M 0.67%
175,000
OBSV
33
DELISTED
ObsEva SA Ordinary Shares
OBSV
$2.56M 0.67%
200,000
-350,000
-64% -$4.48M
GNCA
34
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.18M 0.31%
2,000,000
-1,525,000
-43% -$900K
SLDB icon
35
Solid Biosciences
SLDB
$448M
$920K 0.24%
+100,000
New +$920K
GYRE icon
36
Gyre Therapeutics
GYRE
$734M
$811K 0.21%
100,000
-100,000
-50% -$811K
FGEN icon
37
FibroGen
FGEN
$48.4M
$625K 0.16%
+11,500
New +$625K
BHVN
38
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-275,000
Closed -$10.2M
BDSI
39
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-1,000,000
Closed -$3.7M
UROV
40
DELISTED
Urovant Sciences Ltd.
UROV
-300,000
Closed -$1.98M
DRNA
41
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-1,250,000
Closed -$13.4M
MOTS
42
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
-100,000
Closed -$311K
KA
43
DELISTED
Kineta, Inc. Common Stock
KA
-190,000
Closed -$616K
ITCI
44
DELISTED
Intra-Cellular Therapies Inc.
ITCI
0
XBI icon
45
SPDR S&P Biotech ETF
XBI
$5.29B
0
SRPT icon
46
Sarepta Therapeutics
SRPT
$1.98B
-70,000
Closed -$7.64M
MDGL icon
47
Madrigal Pharmaceuticals
MDGL
$9.7B
-900
Closed -$101K
LRMR icon
48
Larimar Therapeutics
LRMR
$337M
-750,000
Closed -$3.71M